Astria Therapeutics Valuation
| ATXS Stock | USD 9.80 0.05 0.51% |
At this time, the firm appears to be undervalued. Astria Therapeutics shows a prevailing Real Value of $12.57 per share. The current price of the firm is $9.8. Our model approximates the value of Astria Therapeutics from analyzing the firm fundamentals such as Return On Equity of -0.31, shares owned by insiders of 0.48 %, and Current Valuation of 384.43 M as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor acquiring undervalued instruments and selling overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Undervalued
Today
Please note that Astria Therapeutics' price fluctuation is somewhat reliable at this time. Calculation of the real value of Astria Therapeutics is based on 3 months time horizon. Increasing Astria Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Astria Therapeutics is useful when determining the fair value of the Astria stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Astria Therapeutics. Since Astria Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Astria Stock. However, Astria Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.8 | Real 12.57 | Hype 9.62 |
The real value of Astria Stock, also known as its intrinsic value, is the underlying worth of Astria Therapeutics Company, which is reflected in its stock price. It is based on Astria Therapeutics' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Astria Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Astria Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Astria Therapeutics helps investors to forecast how Astria stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Astria Therapeutics more accurately as focusing exclusively on Astria Therapeutics' fundamentals will not take into account other important factors: Astria Therapeutics Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Astria Therapeutics's current stock value. Our valuation model uses many indicators to compare Astria Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Astria Therapeutics competition to find correlations between indicators driving Astria Therapeutics's intrinsic value. More Info.Astria Therapeutics is rated below average in price to book category among related companies. It is rated below average in beta category among related companies totaling about 0.18 of Beta per Price To Book. The ratio of Price To Book to Beta for Astria Therapeutics is roughly 5.68 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Astria Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Astria Therapeutics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Astria Therapeutics' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Astria Therapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Astria Therapeutics and how it compares across the competition.
About Astria Therapeutics Valuation
The stock valuation mechanism determines the current worth of Astria Therapeutics on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Astria Therapeutics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Astria Therapeutics based exclusively on its fundamental and basic technical indicators. By analyzing Astria Therapeutics's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Astria Therapeutics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Astria Therapeutics. We calculate exposure to Astria Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Astria Therapeutics's related companies.Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts. Astri Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 29 people.
8 Steps to conduct Astria Therapeutics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Astria Therapeutics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Astria Therapeutics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Astria Therapeutics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Astria Therapeutics' revenue streams: Identify Astria Therapeutics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Astria Therapeutics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Astria Therapeutics' growth potential: Evaluate Astria Therapeutics' management, business model, and growth potential.
- Determine Astria Therapeutics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Astria Therapeutics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Astria Therapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Astria Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 30.1 M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astria Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more information on how to buy Astria Stock please use our How to Invest in Astria Therapeutics guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Astria Stock analysis
When running Astria Therapeutics' price analysis, check to measure Astria Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astria Therapeutics is operating at the current time. Most of Astria Therapeutics' value examination focuses on studying past and present price action to predict the probability of Astria Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Astria Therapeutics' price. Additionally, you may evaluate how the addition of Astria Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
Is Astria Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astria Therapeutics. If investors know Astria will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astria Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Astria Therapeutics is measured differently than its book value, which is the value of Astria that is recorded on the company's balance sheet. Investors also form their own opinion of Astria Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Astria Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astria Therapeutics' market value can be influenced by many factors that don't directly affect Astria Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Astria Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Astria Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astria Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.